Menu
Washingtoner
  • Home
  • Boeing
  • Daryl Guberman
  • Health
  • Aerospace
  • Technology
  • Business
  • ANSI-ANAB
  • Non-profit
Washingtoner

FreezeNit Announces Exclusive Licensing of Novel Non-Toxic Lice Treatment Technology
Washingtoner/10287890

Trending...
  • Umbrella Becomes First FinOps Platform to Support AWS Billing Transfer Onboarding
  • Styrofoam Recycling Returns to Tacoma Recycle Center
  • Altruvest and Financial Executives International Canada Announce Strategic Partnership to Strengthen Nonprofit Boards Across Canada
FreezeNit
Naturally-Derived OTC Gel Eliminates Lice Without Neurotoxins, Launching Spring 2025

MARBLEHEAD, Mass. - Washingtoner -- FreezeNit, a leader in innovative lice treatment solutions, is thrilled to announce the exclusive licensing of a novel over-the-counter (OTC) lice treatment gel designed to provide a safe, naturally-derived, and highly effective alternative to traditional synthetic or pesticide-based lice treatments.

Unlike conventional OTC lice treatments that rely on pesticide-based pyrethroids, which have decreasing efficacy due to lice resistance, this new technology works by a purely mechanical method of action to eliminate lice and their eggs. The patented formula is free from harsh chemicals and instead leverages natural abrasives, such as diatomaceous earth and walnut shell powder, orange oil extract, and conditioning agents to physically shred lice and nits, while being gentle on the hair and scalp.

This addition strengthens FreezeNit's growing product portfolio, reinforcing the company's mission to provide clean, effective, science-backed treatments that parents can trust.

"This is an incredibly exciting milestone for FreezeNit," said Joanna Shu, CEO of FreezeNit. "By securing exclusive rights to this novel technology, we're positioned to be on the cutting edge of first aid treatments that are gentle on kids. Traditional lice treatments have failed parents and kids, but with this gel, lice don't stand a chance."

More on Washingtoner
  • Matthew Cossolotto Spotlights Make a Promise Day 2026 Events, Including Official Launch of Harness Your PromisePower and Issuing a "Peace Promise"
  • Spokane Police are investigating a collision on West Airport Drive
  • Landmark Expands Services to Include Specialized Glass and Glazing Solutions Across Los Angeles
  • As Pentagon Releases Ufo Files, Debut Ya Novel Predicted It All
  • RAATV Premieres Original Reality Series "The Access Index: Jackson" June, 19

✔ Clinically Proven – was shown to be 96% effective in a clinical trial.
✔ No Resistance Issues – Unlike permethrin-based treatments, which have seen increased lice resistance, this technology works mechanically—not chemically—so lice cannot develop immunity.
✔ Patented & Protected – This novel formula and method of action is patented in the U.S., Canada, and the EU, ensuring exclusivity in the market.
✔ Class I, 510(k) Exempt – The FDA-regulated status allows for a fast-tracked market entry.

FreezeNit is actively engaging with retailers, distributors, and healthcare providers to bring this breakthrough lice treatment to families everywhere.

FreezeNit is an innovative healthcare company dedicated to revolutionizing first-aid with safe, effective, and science-backed solutions. By leveraging cutting-edge technology and natural alternatives to neurotoxins, FreezeNit provides families with fast, reliable, and pesticide-free treatments for head lice infestations.  For more information, visit www.FreezeNit.com.

Media Contact
Cathy Henry
cathy@freezenit.com
214-924-5992


Source: FreezeNit

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Tacoma: 2026 Historic Preservation Awards on May 21
  • L2 Aviation Awarded IDIQ Contract by the U.S. Army for M1A2 Abrams Tank
  • Sycor.Rental Named Among 2026 Best Microsoft Dynamics ERP Supply Chain Solutions
  • Veikkaus Appoints New CFO as Finland's Gambling Monopoly Braces for Breakup
  • Spokane: SPD SIU Unit Makes Additional Arrests on Wanted Fugitives
  • ICTPBX Released: White-Label, Multi-Tenant Open Source PBX Platform for ITSPs
  • 5,521 College Athletes Launch Own Merch Stores in Just 30 Days on AthleteMerch.com, Reaching 7,975 Live Storefronts Nationwide
  • Altruvest and Financial Executives International Canada Announce Strategic Partnership to Strengthen Nonprofit Boards Across Canada
  • Free Critical Illness Claim Calculator Launches to the Public
  • HRC Fertility Celebrates Beverly Hills Grand Opening, Spotlighting Fertility Care as Women's Health Month Begins
  • HRC Fertility's Dr. Christo G. Zouves Appointed to San Mateo County Medical Association Board of Directors
  • HealthBook+ and Stonebrook Risk Solutions Partner to Bring Predictive Intelligence to Healthcare Risk
  • Umbrella Becomes First FinOps Platform to Support AWS Billing Transfer Onboarding
  • Tacoma City Council Reaffirms Commitment to Immigrants and Refugees, Supports Ongoing State and Federal Advocacy
  • RECYCLEXPERT FZE Strengthens Leadership in Data Destruction UAE and GCC with Certified Secure ITAD Services
  • Assymetrix Launches the Deepest Independent Prediction Market Data API
  • City of Tacoma Highlights Environmental Progress and Community Investments in 2025 Climate Action Report
  • CCHR: 'Plant-Based' Psychedelics Push Masks Synthetic Drugs and Billion-Dollar Profits
  • Spokane: Final Day to Request a Disposal Pass Is Friday, May 8
  • Spokane: Council Approves Updates to Mobile Food Truck Regulations
_catLbl0 _catLbl1

Popular on Washingtoner

  • City Council to Discuss ‘Connect Tacoma’ Transportation Levy Replacement at April 14 Study Session
  • Acuvance Appoints Sandeep Sabharwal to Board of Directors, Strengthening Leadership to Support Continued Platform Growth
  • MainConcept Announces Multiview Encoding for Apple Immersive Video
  • YOKE Expands NIL Club Into Athlete-Led Commerce With Athlete Merch Launch
  • Sycor Introduces Spring Release 2026 of Sycor.Rental with AI-Driven Innovations and Enhanced Service Processes
  • Bold Beauty Project Announces Exhibition at Palazzo Mora Venice, Italy
  • Financial Educator Jessica Perrone Launches Free "3 Stages of Building Wealth" Course for Women
  • Card makers turn to Pink and Main for tools to support their craft
  • Clash of Prompts: The World's First AI Prompt Battle Royale
  • Lucky Envelope Brewing Celebrates 11th Anniversary

Similar on Washingtoner

  • Southern California E-Bike Fatalities Raise Urgent Safety Concerns for Families
  • VeneerVibe Releases 2026 Snap-On Veneers Market Report
  • Veikkaus Appoints New CFO as Finland's Gambling Monopoly Braces for Breakup
  • 5,521 College Athletes Launch Own Merch Stores in Just 30 Days on AthleteMerch.com, Reaching 7,975 Live Storefronts Nationwide
  • Free Critical Illness Claim Calculator Launches to the Public
  • HRC Fertility Celebrates Beverly Hills Grand Opening, Spotlighting Fertility Care as Women's Health Month Begins
  • HRC Fertility's Dr. Christo G. Zouves Appointed to San Mateo County Medical Association Board of Directors
  • HealthBook+ and Stonebrook Risk Solutions Partner to Bring Predictive Intelligence to Healthcare Risk
  • CCHR: 'Plant-Based' Psychedelics Push Masks Synthetic Drugs and Billion-Dollar Profits
  • L.A. Watts Summer Games Announces Free Pelé Tribute Event at Magic Johnson Park
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute